[Long-term treatment with cabergoline in pregnancy and neonatal outcome: report of a clinical case].
Hyperprolactinemia is one of the causes of sterility. Cabergoline is indicated in cases resistant to bromocriptine, but, usually, its administration is interrupted at the beginning of the pregnancy. A case of prolonged treatment with cabergoline during pregnancy is reported, without teratogenic effects on the fetus.
de Turris
P
P
Cattedra di Neonatologia, Università Cattolica del Sacro Cuore, Roma.
Venuti
L
L
Zuppa
A A
AA
D000328:Adult; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011256:Pregnancy Outcome; D013997:Time Factors
D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline